Bioxyne Ltd
ASX:BXN

Watchlist Manager
Bioxyne Ltd Logo
Bioxyne Ltd
ASX:BXN
Watchlist
Price: 0.04 AUD
Market Cap: 87.6m AUD
Section:
 

Relative Value

BXN doesn't have a meaningful market cap.

The Relative Value of one BXN stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.04 AUD, Bioxyne Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BXN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

3
P/S
P/S
Price to Sales
3
vs History
66
vs Industry
18
Median 3Y
3.1
Median 5Y
4
Industry
1.1
More Details
17.7
P/E
P/E
Price to Earnings
17.7
vs History
14
vs Industry
Median 3Y
-2.3
Median 5Y
-5.5
Industry
17.8
More Details
13.8
P/OCF
P/OCF
Price to OCF
13.8
vs History
34
vs Industry
9
Median 3Y
-6.3
Median 5Y
-3.5
Industry
11.6
More Details
20.1
P/FCFE
P/FCFE
Price to FCFE
20.1
vs History
23
vs Industry
0
Median 3Y
-7.6
Median 5Y
-7.6
Industry
15.6
More Details
7
P/B
P/B
Price to Book Value
7
vs History
31
vs Industry
4
Median 3Y
6.5
Median 5Y
5.9
Industry
1.5
More Details
2.8
EV/S
EV/S
Enterprise Value to Sales
2.8
vs History
61
vs Industry
20
Median 3Y
2.8
Median 5Y
3.3
Industry
1.2
More Details
7.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.7
vs History
52
vs Industry
29
Median 3Y
7.8
Median 5Y
8.7
Industry
4
More Details
19.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.9
vs History
14
vs Industry
10
Median 3Y
-6.8
Median 5Y
-10.3
Industry
10.4
More Details
19.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
19.9
vs History
14
vs Industry
14
Median 3Y
-6.8
Median 5Y
-10.3
Industry
13.5
More Details
12.7
EV/OCF
EV/OCF
Enterprise Value to OCF
12.7
vs History
34
vs Industry
10
Median 3Y
-6
Median 5Y
-3.3
Industry
12.5
More Details
19
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
19
vs History
25
vs Industry
Median 3Y
-7.1
Median 5Y
-5.8
Industry
15.7
More Details
13.2
EV/IC
EV/IC
Enterprise Value to IC
13.2
vs History
38
vs Industry
4
Median 3Y
10
Median 5Y
10
Industry
1.2
More Details

Multiples Across Competitors

BXN Competitors Multiples
Bioxyne Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Bioxyne Ltd
ASX:BXN
86.6m AUD 3 17.7 19.9 19.9
FR
L'Oreal SA
PAR:OR
189.7B EUR 4.3 31 18 21.9
UK
Unilever PLC
LSE:ULVR
113.5B GBP 2.2 22.8 201.2 233.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.6T INR 8.8 51.8 37.6 41.6
UK
HALEON PLC
LSE:HLN
33.6B GBP 3 23.3 14 15.9
US
Estee Lauder Companies Inc
NYSE:EL
37.9B USD 2.6 -40.8 20.7 34.2
DE
Beiersdorf AG
XETRA:BEI
20.2B EUR 2.1 22.9 11.3 14.4
JP
Kao Corp
TSE:4452
2.9T JPY 1.7 23.6 11.2 17.2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR 8.6 70.1 43.5 47.7
IN
Dabur India Ltd
NSE:DABUR
923.2B INR 7.2 51 38.3 47.4
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD 855.7 -4 624.4 -6 373.4 -6 360.4
P/E Multiple
Earnings Growth PEG
AU
Bioxyne Ltd
ASX:BXN
Average P/E: 34.9
17.7
N/A N/A
FR
L'Oreal SA
PAR:OR
31
8%
3.9
UK
Unilever PLC
LSE:ULVR
22.8
15%
1.5
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
51.8
8%
6.5
UK
HALEON PLC
LSE:HLN
23.3
12%
1.9
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -40.8 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
22.9
8%
2.9
JP
Kao Corp
TSE:4452
23.6
13%
1.8
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
70.1
19%
3.7
IN
Dabur India Ltd
NSE:DABUR
51
12%
4.3
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -4 624.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Bioxyne Ltd
ASX:BXN
Average EV/EBITDA: 41.6
19.9
N/A N/A
FR
L'Oreal SA
PAR:OR
18
5%
3.6
UK
Unilever PLC
LSE:ULVR
201.2
1%
201.2
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
37.6
8%
4.7
UK
HALEON PLC
LSE:HLN
14
4%
3.5
US
Estee Lauder Companies Inc
NYSE:EL
20.7
15%
1.4
DE
Beiersdorf AG
XETRA:BEI
11.3
-1%
N/A
JP
Kao Corp
TSE:4452
11.2
8%
1.4
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
43.5
13%
3.3
IN
Dabur India Ltd
NSE:DABUR
38.3
11%
3.5
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 373.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Bioxyne Ltd
ASX:BXN
Average EV/EBIT: 49.4
19.9
N/A N/A
FR
L'Oreal SA
PAR:OR
21.9
6%
3.7
UK
Unilever PLC
LSE:ULVR
233.7
1%
233.7
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
41.6
9%
4.6
UK
HALEON PLC
LSE:HLN
15.9
4%
4
US
Estee Lauder Companies Inc
NYSE:EL
34.2
25%
1.4
DE
Beiersdorf AG
XETRA:BEI
14.4
-2%
N/A
JP
Kao Corp
TSE:4452
17.2
N/A N/A
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
47.7
13%
3.7
IN
Dabur India Ltd
NSE:DABUR
47.4
11%
4.3
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -6 360.4 N/A N/A

See Also

Summary
BXN intrinsic value, competitors valuation, and company profile.
DCF Valuation
BXN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BXN stock valuation using valuation multiples.
Wall Street Estimates
BXN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BXN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 308,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.